DNMTi/HDACi Combined Epigenetic Targeted Treatment Induces Reprogramming of Myeloma Cells in the Direction of Normal Plasma Cells
British Journal of Cancer - United Kingdom
doi 10.1038/s41416-018-0025-x
Full Text
Open PDFAbstract
Available in full text
Date
March 2, 2018
Authors
Publisher
Springer Science and Business Media LLC